Soleus Capital Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,517,478
| Closed | -$4.43M | – | 85 |
|
|
2024
Q3 | $4.43M | Sell |
2,517,478
-1,383,836
| -35% | -$2.44M | 0.34% | 62 |
|
|
2024
Q2 | $5.34M | Sell |
3,901,314
-163,883
| -4% | -$225K | 0.47% | 60 |
|
|
2024
Q1 | $14M | Hold |
4,065,197
| – | – | 1.04% | 29 |
|
|
2023
Q4 | $10M | Sell |
4,065,197
-291,000
| -7% | -$716K | 1.11% | 29 |
|
|
2023
Q3 | $7.41M | Buy |
4,356,197
+35,000
| +0.8% | +$59.5K | 0.68% | 39 |
|
|
2023
Q2 | $13M | Hold |
4,321,197
| – | – | 1.44% | 19 |
|
|
2023
Q1 | $11.6M | Buy |
4,321,197
+100,800
| +2% | +$270K | 1.2% | 23 |
|
|
2022
Q4 | $34.8M | Buy |
4,220,397
+819,894
| +24% | +$6.76M | 5% | 4 |
|
|
2022
Q3 | $26.2M | Buy |
3,400,503
+137,800
| +4% | +$1.06M | 3.56% | 7 |
|
|
2022
Q2 | $9.3M | Buy |
3,262,703
+747,279
| +30% | +$2.13M | 1.45% | 24 |
|
|
2022
Q1 | $12.6M | Hold |
2,515,424
| – | – | 1.62% | 22 |
|
|
2021
Q4 | $49.4M | Hold |
2,515,424
| – | – | 4.94% | 3 |
|
|
2021
Q3 | $74.1M | Sell |
2,515,424
-278,809
| -10% | -$8.21M | 11.54% | 1 |
|
|
2021
Q2 | $118M | Sell |
2,794,233
-385,129
| -12% | -$16.3M | 18.21% | 1 |
|
|
2021
Q1 | $162M | Hold |
3,179,362
| – | – | 29.12% | 1 |
|
|
2020
Q4 | $108M | Buy |
+3,179,362
| New | +$108M | 14.27% | 1 |
|